Stay updated with breaking news from Relapsed Multiple. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vofatamabis under clinical development by Fusion Pharmaceuticals and currently in Phase I for Relapsed Multiple Myeloma.
Advanced therapy is an ideal treatment option for multiple myeloma and may benefit patients who couldn’t get cured by other treatment options. TheHealthSite.com
*SHA acting as mute spectator, fails to respond Govind Sharma JAMMU, June 22: Several patients suffering with a specific type of blood cancer ‘Relapsed Multiple Myeloma’ are on the verge of dying as the drug they need to be given on urgent basis, are not included in the primary package code under Ayushman Bharat scheme. A number of such cancer patients or their attendants contacted Excelsior and narrated their woes as to how they have been left to die by […]